Year 2 Stations
Data Interpretation
ECG, blood results, urine dipstick, and imaging for all 4 Year 2 communication stations. Use alongside the station file. Reveal answers when ready.
Mr Dennis Hartley, 67. Retired painter and decorator. 3 days of painless visible haematuria throughout the stream. Ex-smoker (30 pack-years). On aspirin 75mg for known AF. Uncle had bladder cancer. Lost 4kg over 3 months. GP has ordered urgent investigations.
AF + aspirin + painless haematuria in a 67-year-old male ex-smoker with occupational chemical exposure = urgent 2-week-wait urology referral required. The antiplatelet use must be documented but does not explain away the haematuria — bladder cancer must be excluded first.
Three findings = AF: (1) irregularly irregular rhythm, (2) absent P waves, (3) fibrillatory baseline. If QRS is broad, consider AF with bundle branch block or AF with aberrant conduction — but narrow complex AF = simple AF with ventricular rate response.
| Test | Result | Reference range | Flag |
|---|---|---|---|
| Full Blood Count | |||
| Haemoglobin (Hb) | 119 g/L | 130–170 g/L (M) | Low |
| MCV | 84 fL | 80–100 fL | Normal |
| White cell count | 7.2 × 10⁹/L | 4–11 × 10⁹/L | Normal |
| Platelets | 218 × 10⁹/L | 150–400 × 10⁹/L | Normal |
| Renal Function (U&E) | |||
| Sodium (Na⁺) | 138 mmol/L | 133–146 mmol/L | Normal |
| Potassium (K⁺) | 4.1 mmol/L | 3.5–5.3 mmol/L | Normal |
| Urea | 6.8 mmol/L | 2.5–7.8 mmol/L | Normal |
| Creatinine | 108 µmol/L | 59–104 µmol/L (M) | Borderline ↑ |
| eGFR | 58 mL/min/1.73m² | > 60 mL/min/1.73m² | Stage G3a CKD |
| Inflammatory Markers | |||
| CRP | 42 mg/L | < 5 mg/L | Raised |
| ESR | 64 mm/hr | < 20 mm/hr (M) | Raised |
| Tumour Markers | |||
| PSA (Prostate Specific Antigen) | 2.1 µg/L | < 4.0 µg/L (age 60–69) | Normal |
Anaemia + raised CRP/ESR + haematuria + 4kg weight loss + 30 pack-year history + 40 years of chemical exposure = strong suspicion for bladder transitional cell carcinoma. Refer urgently via 2-week-wait pathway for cystoscopy and CT urogram.
Unexplained visible haematuria in a patient aged ≥ 45 = urgent 2-week-wait referral regardless of other findings. Mr Hartley meets this criterion (age 67, visible haematuria). Additional risk factors (smoking, occupational exposure, weight loss) make this even more pressing.
No radio-opaque calcific densities identified within the renal tracts bilaterally. Renal outlines appear within normal limits on plain radiograph. Bladder not adequately visualised. Bony pelvis and lower lumbar spine show mild degenerative change.
IMPRESSION:
No radio-opaque renal tract calculi. This does not exclude soft tissue pathology. CT urogram is recommended as the investigation of choice for haematuria workup.
KUB is increasingly considered an outdated first-line investigation for haematuria. NICE and the British Association of Urological Surgeons recommend CT urogram + flexible cystoscopy as the standard haematuria workup. KUB may be used in known stone disease follow-up but is insufficient to exclude malignancy.
If asked "what investigation would you request?": CT urogram + urine cytology + cystoscopy (via urology 2WW referral). Do not say "KUB and renal ultrasound" for a 67-year-old with painless visible haematuria and red flags — this is insufficient and would delay cancer diagnosis.
Mrs Patricia Osei, 71. Admitted after husband found her confused with right-sided weakness. CT + MRI confirmed left-sided ischaemic stroke in MCA territory. Treated with thrombolysis. Mild residual right arm weakness, otherwise improving. PMHx: hypertension. No known AF prior to admission.
This ECG is clinically critical — it identifies the likely cause of her stroke (cardioembolic from AF) and drives the secondary prevention strategy (anticoagulation, rate control). Without this ECG finding, she might be given antiplatelet therapy alone, which would be insufficient for AF-related stroke.
| Test | Result | Reference range | Flag |
|---|---|---|---|
| Metabolic / Glucose | |||
| Blood glucose (random) | 8.4 mmol/L | < 7.8 mmol/L (random) | Borderline ↑ |
| HbA1c | 41 mmol/mol | < 48 mmol/mol | Normal |
| Lipids | |||
| Total cholesterol | 6.8 mmol/L | < 5.0 mmol/L | High |
| LDL cholesterol | 4.2 mmol/L | < 3.0 mmol/L | High |
| HDL cholesterol | 1.4 mmol/L | > 1.0 mmol/L (F) | Normal |
| Triglycerides | 2.1 mmol/L | < 1.7 mmol/L | Mild ↑ |
| Coagulation | |||
| PT / INR | 1.0 | 0.9–1.2 | Normal |
| APTT | 28 seconds | 26–37 seconds | Normal |
| Renal & Electrolytes | |||
| Sodium | 136 mmol/L | 133–146 mmol/L | Normal |
| Potassium | 3.8 mmol/L | 3.5–5.3 mmol/L | Normal |
| eGFR | 72 mL/min/1.73m² | > 60 mL/min/1.73m² | Normal |
Based on these bloods + ECG, her secondary prevention should include: (1) DOAC (anticoagulation for AF — timing per stroke severity), (2) atorvastatin 80mg (dyslipidaemia + ischaemic stroke), (3) antihypertensive optimisation, (4) lifestyle advice — no smoking, alcohol guidance, diet. She does not need antiplatelet therapy if anticoagulated.
No intracranial haemorrhage. No hyperdense MCA sign. Subtle loss of grey-white matter differentiation in left MCA territory, in keeping with early ischaemic change. No midline shift. Ventricles normal. No space-occupying lesion.
IMPRESSION:
Findings consistent with left MCA territory acute ischaemic stroke. No haemorrhage. Patient eligible for thrombolysis if within time window and clinical criteria met.
CT: fast, rules out haemorrhage, often done first. MRI DWI: most sensitive for acute ischaemia, can detect within minutes, also shows extent of infarct and penumbra. Both are used in stroke — CT first to exclude haemorrhage, then MRI for definitive characterisation and stroke cause workup.
Mrs Shirley Dawson, 64. 3-month progressive breathlessness. Orthopnoea (3 pillows), bilateral ankle oedema, dry cough × 6 weeks. On ramipril + amlodipine for hypertension. Kept pigeons for 20 years (sold 6 months ago). Ex-smoker (15 pack-years). BMI 34. Two differentials: heart failure vs hypersensitivity pneumonitis (bird fancier's lung).
S wave in V1 + R wave in V5 (or V6) > 35mm = LVH. Other criteria: Cornell (R in aVL > 11mm), or Romhilt-Estes scoring. Sensitivity is only ~20–30% but specificity is ~95% — a positive result is meaningful even if many LVH cases are ECG-negative.
| Test | Result | Reference range | Flag |
|---|---|---|---|
| Cardiac Biomarker | |||
| NT-proBNP | 1840 ng/L | < 125 ng/L (<75yrs) | Significantly raised |
| Thyroid Function | |||
| TSH | 2.1 mU/L | 0.4–4.0 mU/L | Normal |
| Free T4 | 14.8 pmol/L | 9–25 pmol/L | Normal |
| Renal & Electrolytes | |||
| Sodium | 131 mmol/L | 133–146 mmol/L | Low |
| Potassium | 4.4 mmol/L | 3.5–5.3 mmol/L | Normal |
| Urea | 10.2 mmol/L | 2.5–7.8 mmol/L | Raised |
| Creatinine | 110 µmol/L | 45–90 µmol/L (F) | Borderline ↑ |
| eGFR | 54 mL/min/1.73m² | > 60 mL/min/1.73m² | CKD G3a |
| Liver Function (Cardiac screen) | |||
| ALT | 58 U/L | 7–45 U/L | Mildly raised |
| Albumin | 32 g/L | 35–50 g/L | Low |
| Bilirubin | 14 µmol/L | < 21 µmol/L | Normal |
NT-proBNP > 400 ng/L + clinical features of heart failure = urgent echocardiogram within 2 weeks (NICE NG106). Echo will determine ejection fraction (HFrEF vs HFpEF), valve pathology, and guide treatment. Do not withhold treatment pending echo if clinically decompensated.
Cardiac silhouette enlarged — CTR estimated at 0.58. Bilateral pleural effusions, greater on the left. Kerley B lines identified at lung bases bilaterally. Upper lobe blood diversion. No focal consolidation. No pneumothorax.
IMPRESSION:
CXR appearances in keeping with heart failure with pulmonary oedema. Bilateral pleural effusions likely cardiac in aetiology. Recommend echocardiography and cardiology review.
Heart failure: bilateral, perihilar (bat-wing), cardiomegaly, effusions, Kerley B lines, upper lobe diversion. Chest infection/pneumonia: usually unilateral or lobar consolidation, air bronchograms, no cardiomegaly. Always check the cardiac silhouette when interpreting any CXR — it's frequently missed under time pressure.
Mr Raymond Cole, 74. Retired postman. Severe right knee osteoarthritis — failed physiotherapy and two steroid injections. BMI 28. No significant cardiac or respiratory comorbidities. Lives alone. Being considered for total knee replacement. Pre-operative assessment results available.
Describing a normal ECG confidently is as important as identifying abnormalities. Structure your answer: rate, rhythm, axis, P waves, PR interval, QRS duration and morphology, ST segments, T waves, QTc. "Normal sinus rhythm at X bpm, normal axis, normal intervals, no ST or T wave changes" is a complete normal ECG interpretation.
| Test | Result | Reference range | Flag |
|---|---|---|---|
| Full Blood Count | |||
| Haemoglobin (Hb) | 138 g/L | 130–170 g/L (M) | Normal |
| MCV | 88 fL | 80–100 fL | Normal |
| Platelets | 244 × 10⁹/L | 150–400 × 10⁹/L | Normal |
| Coagulation | |||
| PT / INR | 1.1 | 0.9–1.2 | Normal |
| APTT | 30 seconds | 26–37 seconds | Normal |
| Renal & Metabolic | |||
| Sodium | 140 mmol/L | 133–146 mmol/L | Normal |
| Potassium | 4.2 mmol/L | 3.5–5.3 mmol/L | Normal |
| Creatinine | 88 µmol/L | 59–104 µmol/L (M) | Normal |
| eGFR | 72 mL/min/1.73m² | > 60 mL/min/1.73m² | Normal |
| Glucose (fasting) | 5.2 mmol/L | 3.9–5.5 mmol/L | Normal |
| Inflammatory Markers | |||
| CRP | 18 mg/L | < 5 mg/L | Mildly raised |
| ESR | 32 mm/hr | < 20 mm/hr (M) | Mildly raised |
FBC: anaemia (transfusion risk), infection (WCC). Coagulation: bleeding risk, anticoagulant status. U&E: renal function (affects drug choice, IV fluid management, contrast if needed). Glucose/HbA1c: diabetes affects wound healing and infection risk. Group & save: TKR requires crossmatch in case of transfusion. CRP/ESR: exclude active infection contraindication.
Severe medial compartment joint space loss with bone-on-bone contact. Prominent medial osteophytes. Subchondral sclerosis medially. Relative preservation of the lateral compartment. No fracture.
IMPRESSION:
Kellgren-Lawrence Grade 4 osteoarthritis, right knee, medial compartment predominant. Appearances support surgical referral.
Showing a patient their X-ray is a powerful tool in SDM — it helps them understand why conservative treatment has limited benefit when bone is contacting bone. "This dark line is the space where your cartilage should be — there's very little left" makes the imaging tangible and helps patients make an informed decision about surgery.